{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:01:24Z","timestamp":1793120484309,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Adv Pharm Technol Res"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/2231-4040.157981","type":"journal-article","created":{"date-parts":[[2016,3,13]],"date-time":"2016-03-13T23:28:04Z","timestamp":1457911684000},"page":"136","source":"Crossref","is-referenced-by-count":36,"title":["Comparison of the efficacy of cardamom (Elettaria cardamomum) with pioglitazone on dexamethasone-induced hepatic steatosis, dyslipidemia, and hyperglycemia in albino rats"],"prefix":"10.4103","volume":"6","author":[{"given":"GM","family":"Nitasha Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendra","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Vinodraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Chandralekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mathai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2231-4040.157981-1","first-page":"228","volume-title":"The worldwide epidemiology of type 2 diabetes mellitus - Present and future perspectives","author":"Chen","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"key-10.4103\/2231-4040.157981-2","first-page":"419","volume-title":"Insulin resistance, diabetes, and cardiovascular risk","author":"Paneni","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"key-10.4103\/2231-4040.157981-3","first-page":"31","volume-title":"A study on anti-hyper lipidemic effect of oral ad-ministration of cardamom in Wistar albino rats","author":"Sailesh","year":"2013","journal-title":"Narayana Med J"},{"key":"key-10.4103\/2231-4040.157981-4","first-page":"419","volume-title":"Prevention of dexamethasone-and fructose-induced insulin resistance in rats by SH-01D, a herbal preparation","author":"Shalam","year":"2006","journal-title":"Indian J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7613","issn-type":"print"},{"key":"key-10.4103\/2231-4040.157981-5","first-page":"503","volume-title":"Blood pressure lowering, fibrinolysis enhancing and antioxidant activities of cardamom (Elettaria cardamomum)","author":"Verma","year":"2009","journal-title":"Indian J Biochem Biophys"},{"key":"key-10.4103\/2231-4040.157981-6","first-page":"371","volume-title":"In vitro investigation of the potential immunomodulatory and anti-cancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum)","author":"Majdalawieh","year":"2010","journal-title":"J Med Food"},{"key":"key-10.4103\/2231-4040.157981-7","first-page":"437","volume-title":"Cardamom extract as inhibitor of human platelet aggregation","author":"Suneetha","year":"2005","journal-title":"Phytother Res"},{"key":"key-10.4103\/2231-4040.157981-8","first-page":"2777","volume-title":"Traditional herbal remedies used for the Treatment of diabetes from district Attock (Pakistan)","author":"Ahmad","year":"2009","journal-title":"Pak J Bot"},{"key":"key-10.4103\/2231-4040.157981-9","unstructured":"Pushpangadan P, Prakash D. Herbal Nutraceutical Formulation for Diabetics and Process for Preparing the same. US 20060147561 A1. Available from: http:\/\/www.google.com\/patents\/US20060147561. [Last accessed on 2014 Aug 12]."},{"key":"key-10.4103\/2231-4040.157981-10","first-page":"339","volume-title":"Development of insulin resistance in experimental animals during long-term glucocorticoid treatment","author":"Selyatitskaya","year":"2002","journal-title":"Bull Exp Biol Med"},{"key":"key-10.4103\/2231-4040.157981-11","first-page":"23","volume-title":"Mechanisms involved in the side effects of glucocorticoids","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"key-10.4103\/2231-4040.157981-12","first-page":"321","volume-title":"Dexamethasone-induced insulin resistance shows no gender difference in healthy humans","author":"Binnert","year":"2004","journal-title":"Diabetes Metab"},{"key":"key-10.4103\/2231-4040.157981-13","first-page":"2119","volume-title":"Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor","author":"Ruzzin","year":"2005","journal-title":"Diabetologia"},{"key":"key-10.4103\/2231-4040.157981-14","first-page":"1066","volume-title":"Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome","author":"Whorwood","year":"2002","journal-title":"Diabetes"},{"key":"key-10.4103\/2231-4040.157981-15","first-page":"1418","volume-title":"Tissue-specific dysregulation of cortisol metabolism in human obesity","author":"Rask","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2231-4040.157981-16","first-page":"7088","volume-title":"Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice","author":"Paterson","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2231-4040.157981-17","first-page":"2166","volume-title":"A transgenic model of visceral obesity and the metabolic syndrome","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"key-10.4103\/2231-4040.157981-18","doi-asserted-by":"crossref","unstructured":"Duseja A. Nonalcoholic fatty liver disease in India - A lot done, yet more required! Indian J Gastroenterol 2010;29:217-25.","DOI":"10.1007\/s12664-010-0069-1"},{"key":"key-10.4103\/2231-4040.157981-19","first-page":"7","volume-title":"Changing definitions of metabolic syndrome","author":"Parikh","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"key-10.4103\/2231-4040.157981-20","first-page":"550","volume-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","author":"Stumvoll","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2231-4040.157981-21","first-page":"1106","volume-title":"Thiazolidinediones","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2231-4040.157981-22","first-page":"188","volume-title":"Current treatment of non-alcoholic fatty liver disease","author":"Ahmed","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"key-10.4103\/2231-4040.157981-23","first-page":"250","volume-title":"Evaluation of acute toxicity of pioglitazone in mice","author":"Chinnam","year":"2012","journal-title":"Toxicol Int","ISSN":"https:\/\/id.crossref.org\/issn\/0971-6580","issn-type":"print"},{"key":"key-10.4103\/2231-4040.157981-24","first-page":"555","volume-title":"The impact of pioglitazone on bladder cancer and cardiovascular events","author":"Lee","year":"2014","journal-title":"Consult Pharm"},{"key":"key-10.4103\/2231-4040.157981-25","doi-asserted-by":"crossref","unstructured":"Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications. Gastroenterology 2012;142:711-25.e6.","DOI":"10.1053\/j.gastro.2012.02.003"},{"key":"key-10.4103\/2231-4040.157981-26","first-page":"769","volume-title":"Pioglitazone in the treatment of NASH: The role of adiponectin","author":"Gastaldelli","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/2231-4040.157981-27","first-page":"5297","volume-title":"Antioxidant therapy and drugs interfering with lipid metabolism: Could they be effective in NAFLD patients?","author":"Musso","year":"2013","journal-title":"Curr Pharm Des"}],"container-title":["Journal of Advanced Pharmaceutical Technology & Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:25:02Z","timestamp":1786713902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2231-4040.157981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"alternative-id":["157981"],"URL":"https:\/\/doi.org\/10.4103\/2231-4040.157981","relation":{},"ISSN":["2231-4040"],"issn-type":[{"value":"2231-4040","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}